ARISTADA INITIO KIT

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jun 29, 2018

   8 yr 1 mo ago

2. Today

3. Patent 10112903 expires

   Listed drug substance patent expiration.

   Jun 24, 2030

   in 4 yr 1 mo

4. Patent 8796276 expires

   Listed method-of-use patent (U-543) expiration.

   Jun 24, 2030

   in 4 yr 1 mo

5. Patent 8431576 expires

   Listed drug substance patent expiration.

   Oct 26, 2030

   in 4 yr 5 mo

6. Patent 10688091 expires

   Listed drug product patent expiration.

   Aug 17, 2035

   in 9 yr 4 mo

7. Patent 10849894 expires

   Listed method-of-use patent (U-543) expiration.

   Aug 17, 2035

   in 9 yr 4 mo

8. Patent 11154552 expires

   Listed drug product patent expiration.

   Aug 17, 2035

   in 9 yr 4 mo

9. Patent 10016415 expires

   Listed drug product patent expiration.

   Sep 08, 2035

   in 9 yr 4 mo

10. Patent 11273158 expires

    Listed method-of-use patent (U-543) expiration.

    Apr 06, 2039

    in 13 yr

11. Patent 12251381 expires

    Listed method-of-use patent (U-543) expiration.

    Apr 06, 2039

    in 13 yr

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• ARISTADABrand (NDA)

  NDA 207533 · ALKERMES INC

  2015

Listed patents (9)